Skip to content

ANI Pharmaceuticals ANIP Income taxes payable - foreign

Income taxes payable - foreign at other companies

FAN
Diamondback EnergyFANG
$517M-6.0%
TEC
Bio-TechneTECH
$2.97M-18.1%
Lam Research logo
Lam ResearchLRCX
$188.6M-39.0%
Cisco Systems, Inc. logo
Cisco Systems, Inc.CSCO
$173M-90.5%
Halliburton logo
HalliburtonHAL
$384M+6.1%
Trimble Inc. logo
Trimble Inc.TRMB
$15.5M-94.4%

Other financials

Income statement

See full
Revenue$237.5M+20.5%
Gross profit$143.9M+16.0%
Operating income$38.9M+48.5%
Net income$29.5M+88.1%
EPS (diluted)$1.28+85.5%

Balance sheet

See full
Cash & equivalents$311.2M+108%
Total debt$305.3M-3.5%
Total equity$562.3M+34.3%
Total assets$1.4B+10.0%

Cash flow

See full
Operating cash flow$58.4M+66.8%
CapEx$6.1M+146%
Free cash flow$52.3M+60.8%

Valuation

See full
Market cap$1.88B+18.3%
Enterprise value$1.87B+5.8%
P/E20.4×
P/S-0.3×

Profitability

See full
Gross margin60.8%+1.5pp
Operating margin13.4%
Net margin10%+8.1pp
FCF margin20.7%+10.8pp

Returns & leverage

See full
Return on equity18.8%+15.6pp
Debt / equity0.5×-0.2×
Current ratio3.1×+0.5×

Where this comes from

Reported directly by ANI Pharmaceuticals in its filing.

Tagged under the XBRL concept anip:ForeignTaxesPayableCurrent.

The official record: ANI Pharmaceuticals’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about ANI Pharmaceuticals's income taxes payable - foreign.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ANI Pharmaceuticals's income taxes payable - foreign?
ANI Pharmaceuticals (ANIP) reported income taxes payable - foreign of $948K in Q4 2025.
What does income taxes payable - foreign mean?
This represents the current portion of income tax obligations owed to foreign tax jurisdictions arising from operations conducted outside the company's home country. It reflects the tax impact of international business activities and the company's compliance with local tax laws. Tracking this helps investors assess the company's global tax exposure and the efficiency of its international tax planning.